Titan Pharmaceuticals Inc. posted a fourth-quarter net loss nearly triple the previous year's as the company ramped up research and development
South San Francisco-based Titan (OTCBB: TTNP) had a fourth-quarter net loss of $4.3 million, or 5 cents per share, compared with a loss of $1.5 million, or 2 cents per share, in the same quarter of 2009.
Showing posts with label Titan Pharmaceuticals. Show all posts
Showing posts with label Titan Pharmaceuticals. Show all posts
Friday, March 25, 2011
Wednesday, March 16, 2011
Titan to borrow $20M from Deerfield Management
Titan Pharmaceuticals Inc. will borrow $20 million from Deerfield Management and use the money to pay off another loan from Oxford Finance Corp.
South San Francisco-based Titan (OTCBB: TTNP) will also spend some of the money on developing its drug Probuphine and on general company costs.
The company, led by President Sunil Bhonsle, will get the loan around April 4.
South San Francisco-based Titan (OTCBB: TTNP) will also spend some of the money on developing its drug Probuphine and on general company costs.
The company, led by President Sunil Bhonsle, will get the loan around April 4.
Subscribe to:
Posts (Atom)